Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 465.00
Bid: 460.00
Ask: 470.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.174%)
Open: 465.00
High: 465.00
Low: 465.00
Prev. Close: 465.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointments

26 Apr 2022 15:05

RNS Number : 4137J
Aquis Exchange PLC
26 April 2022
 

26 April 2022

Aquis Exchange PLC

("Aquis", or the "Company")

 

Board Appointments

 

Further to the Company's announcement on 29 March 2022 and approval at the Annual General Meeting held earlier today, Aquis Exchange PLC (AQX.L, AQX.PL), the exchange services company, is pleased to announce that Richard Fisher has been appointed to the Board as Chief Financial Officer, and Dr. Ruth Wandhöfer and Fields Wicker-Miurin OBE have been appointed to the Board as Independent Non-Executive Directors, with immediate effect.

 

Richard Fisher first joined Aquis as Director of Finance in April 2021 and is based in London. Prior to joining Aquis, Richard was Director of Finance at Redwood Bank and other previous roles include Chief Accountant at RBS Group. Richard has assumed his duties as the Company's Chief Financial Officer following an orderly handover with current Chief Financial Officer, Jonathan Clelland. Jonathan will retain his roles as COO of the Group and CEO of Aquis Exchange Europe, and remain on the Board.

 

Dr. Ruth Wandhöfer joins Aquis alongside her duties as an independent Non-Executive Director at Permanent TSB, Digital Identity Net and Gresham Technologies. She also holds the role of Chair of the UK Payment Systems Regulator Panel. Ruth is a strategic adviser to the European Third-Party Payment Provider Association (ETPPA), a Partner at Gauss Ventures, member of the Advisory Board of RTGS.global and part-time CIO at GC Partners. Most recently she was an independent Non-Executive Director of the London Stock Exchange Group and Pendo Systems Inc. Furthermore, she has worked for the Commerzbank Real Estate Fund, the European Commission, the European Banking Federation and at Citi as Managing Director responsible at global level for the Regulatory & Market Strategy of the Treasury and Trade Solutions (TTS) business.

Fields Wicker-Miurin has a distinguished career with over 40 years' experience as an executive in financial services, a social entrepreneur focused on leadership, and a Non-Executive Director and committee chair of the boards of both global companies and government departments. From 1994-7 she led the transformation of the London Stock Exchange and the London equity markets while CFO and Strategy Director and from 2006-7 she was the only non-US member of the NASDAQ Technical Advisory Council. Fields was one of only 10 experts (and the only British one) advising the EU Parliament on financial services harmonisation in the lead-up to the Prospectus Directive. She currently serves as a Non-Executive Director and member and chair of key committees of the main boards of BNP Paribas (the eurozone's largest bank) and Scor (the world's 4th largest reinsurance company) and is Deputy Chair of the Royal College of Art & Design. It is the intention, as part of the Company's succession planning process, that Fields will take over the Senior Independent Director role from Richard Bennett.

Commenting on the appointments Glenn Collinson, Chairman of Aquis Exchange PLC, said:

"We are delighted to announce the three new appointments to the Board, bringing a huge wealth of knowledge and experience to the leadership team, and helping us to drive forward towards our ambitious targets.

 

Richard has been a highly effective Director of Finance at Aquis over the past year, showing strong leadership and expertise. He has gathered considerable experience of the Company since joining which will put him in good stead for his new role as CFO. We are also very pleased to have Jonathan stay on the Board in the key roles of COO and CEO of Aquis Exchange Europe.

 

With Ruth and Fields, we have found people with incredibly impressive careers in financial services. Their highly regarded reputations within the banking industry and with regulators, alongside their expansive experience within the sector will help to drive continued success for the business."

 

Disclosure required pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies

The names of all companies and partnerships of which Richard John Fisher, aged 49, has been a director or partner at any time in the previous five years are set out below:

Current directorships or partnerships:

Previous directorships or partnerships:

None

National Westminster International Holdings B.V.

RBS AA Holdings (UK) Limited

Mr Fisher holds no ordinary shares in Aquis.

Save as set out in this announcement, there are no further details to be disclosed under Rule 17 or Schedule 2(g) of the AIM Rules for Companies in respect of Mr Fisher.

The names of all companies and partnerships of which Dr. Ruth Wandhöfer, aged 46, has been a director or partner at any time in the previous five years are set out below:

Current directorships or partnerships:

Previous directorships or partnerships:

Gresham Technologies PLC

London Stock Exchange Group PLC

Sinonyx Limited

Pendo Systems, Inc

Digital Identity Net U.K. Limited

Permanent Tsb Public Limited Company

Permanent Tsb Group Holdings Public Limited

Leximar Limited

Dr. Wandhöfer holds no ordinary shares in Aquis.

Save as set out in this announcement, there are no further details to be disclosed under Rule 17 or Schedule 2(g) of the AIM Rules for Companies in respect of Dr. Wandhöfer.

The names of all companies and partnerships of which Jane Fields Wicker-Miurin OBE, aged 63, has been a director or partner at any time in the previous five years are set out below:

 

Current directorships or partnerships:

Previous directorships or partnerships:

BNP Paribas S.A.

Prudential Public Limited Company

SCOR SE

SCOR UK Company Limited

Fields holds no ordinary shares in Aquis.

Save as set out in this announcement, there are no further details to be disclosed under Rule 17 or Schedule 2(g) of the AIM Rules for Companies in respect of Fields Wicker-Miurin OBE.

 

Enquiries:

Aquis Exchange PLC via

Alma PR (Financial PR Adviser):

Susie Hudson

Kieran Breheny

 

Tel: +44 (0)20 3405 0209

aquis@almapr.co.uk

 

VSA Capital Limited (AQSE Corporate Adviser)

Andrew Raca

Pascal Wiese

 

Liberum Capital Limited (Nominated Adviser and Joint Broker)

Chris Clarke

Clayton Bush

Edward Thomas

 

Tel: +44(0)20 3005 5000

 

 

 

Tel: +44 (0) 20 3100 2000

Canaccord Genuity Limited (Joint Broker)

Bobbie Hilliam

Patrick Dolaghan

Tel: +44 (0) 20 7523 8000

 

 

Notes to Editors

About Aquis Exchange PLC

Aquis Exchange PLC and its subsidiaries are an exchange services group which operate a pan-European cash equities trading businesses (Aquis Exchange), a growth and regulated primary market (Aquis Stock Exchange/AQSE) and develop/license exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK/Switzerland and in EU27 respectively. Aquis Exchange operates lit and dark order books, covering 16 European markets. For its lit books, Aquis Exchange uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade and does not allow aggressive non-client proprietary trading, which has resulted in lower market impact and signalling risk on Aquis Exchange than other trading venues in Europe.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC is listed on the Aquis Stock Exchange and on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXBSGDSXGDDGDL
Date   Source Headline
18th Apr 20242:30 pmRNSResult of AGM and Confirmation of Board Change
22nd Mar 20247:00 amRNSPublication of Annual Report and Notice of AGM
21st Mar 20247:00 amRNSResults for the year ended 31 December 2023
13th Mar 20247:00 amRNSContract with the Central Bank of Colombia
12th Mar 20247:00 amRNSAquis to Establish New Real Assets Market Segment
26th Feb 20247:00 amRNSAquis launches conditional order functionality
23rd Feb 20247:00 amRNSNotice of Results and Investor Presentation
25th Jan 20247:00 amRNSTrading Update and Notice of Results
23rd Jan 20243:15 pmRNSExercise of Share Options and Total Voting Rights
21st Dec 20231:15 pmRNSDirector/PDMR Notification
29th Nov 20237:00 amRNSAQSE becomes first cloud-based RIE
24th Nov 202312:00 pmRNSDirector/PDMR Notification
2nd Nov 20237:00 amRNSHolding(s) in Company
31st Oct 202311:55 amRNSBoard Change
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 202312:39 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSInterim Results
12th Sep 20237:00 amRNSAquis Markets - Change to Proprietary Trading Rule
7th Sep 20237:00 amRNSNotice of Results and Investor Presentation
6th Sep 20237:00 amRNSAppointment of Nominated Adviser and Joint Broker
7th Aug 20232:15 pmRNSAcquisition of Minority Interest
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAquis launches Dark to Lit Sweep
27th Apr 20237:00 amRNSDirector/PDMR Notification and Issue of Options
25th Apr 20232:18 pmRNSResult of AGM
14th Apr 20237:00 amRNSPublication of Annual Report & Notice of AGM
6th Apr 20231:05 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 202310:55 amRNSDirector/PDMR Shareholding
3rd Apr 20237:01 amRNSDirector/PDMR Shareholdings
3rd Apr 20237:00 amRNSAquis Launches The World’s First 24x7 Exchange
30th Mar 20237:00 amRNSFinal Results
22nd Feb 20237:00 amRNSNotice of Results and Investor Presentation
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSTrading Update and Notice of Results
5th Jan 20237:00 amRNSDirectorate Change
12th Dec 20227:00 amRNSIG Expands UK Trading Offering With AQSE Stocks
24th Nov 20229:13 amRNSDirector/PDMR Notification
23rd Nov 20224:09 pmRNSDirector/PDMR Notification
2nd Nov 20227:00 amRNSNotice of Capital Markets Day
27th Sep 20227:00 amRNSNotice of Capital Markets Day
22nd Sep 20227:00 amRNSInterim Results
5th Sep 202212:00 pmRNSLaunch of new EU dark pool, Aquis Matching Pool
23rd Aug 20227:00 amRNSNotice of Results
6th Jul 202212:00 pmRNSAPEX stocks now trading on Hargreaves Lansdown
30th Jun 202212:49 pmRNSDirector/PDMR Notification and Issue of Options
23rd Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 202212:30 pmRNSExercise of Share Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.